These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 16303136)

  • 1. Destabilization of human IAPP amyloid fibrils by proline mutations outside of the putative amyloidogenic domain: is there a critical amyloidogenic domain in human IAPP?
    Abedini A; Raleigh DP
    J Mol Biol; 2006 Jan; 355(2):274-81. PubMed ID: 16303136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a novel human islet amyloid polypeptide beta-sheet domain and factors influencing fibrillogenesis.
    Jaikaran ET; Higham CE; Serpell LC; Zurdo J; Gross M; Clark A; Fraser PE
    J Mol Biol; 2001 May; 308(3):515-25. PubMed ID: 11327784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-based design and study of non-amyloidogenic, double N-methylated IAPP amyloid core sequences as inhibitors of IAPP amyloid formation and cytotoxicity.
    Kapurniotu A; Schmauder A; Tenidis K
    J Mol Biol; 2002 Jan; 315(3):339-50. PubMed ID: 11786016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of sequential proline substitutions on amyloid formation by human amylin20-29.
    Moriarty DF; Raleigh DP
    Biochemistry; 1999 Feb; 38(6):1811-8. PubMed ID: 10026261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pancreatic beta-cell granule peptides form heteromolecular complexes which inhibit islet amyloid polypeptide fibril formation.
    Jaikaran ET; Nilsson MR; Clark A
    Biochem J; 2004 Feb; 377(Pt 3):709-16. PubMed ID: 14565847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a penta- and hexapeptide of islet amyloid polypeptide (IAPP) with amyloidogenic and cytotoxic properties.
    Tenidis K; Waldner M; Bernhagen J; Fischle W; Bergmann M; Weber M; Merkle ML; Voelter W; Brunner H; Kapurniotu A
    J Mol Biol; 2000 Jan; 295(4):1055-71. PubMed ID: 10656810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Islet amyloid polypeptide: mechanisms of amyloidogenesis in the pancreatic islets and potential roles in diabetes mellitus.
    Johnson KH; O'Brien TD; Betsholtz C; Westermark P
    Lab Invest; 1992 May; 66(5):522-35. PubMed ID: 1573849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of amylin cleavage products provides new insights into the amyloidogenic region of human amylin.
    Nilsson MR; Raleigh DP
    J Mol Biol; 1999 Dec; 294(5):1375-85. PubMed ID: 10600392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design of peptide-based inhibitors of human islet amyloid polypeptide fibrillogenesis.
    Scrocchi LA; Chen Y; Waschuk S; Wang F; Cheung S; Darabie AA; McLaurin J; Fraser PE
    J Mol Biol; 2002 May; 318(3):697-706. PubMed ID: 12054816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Environmental factors differently affect human and rat IAPP: conformational preferences and membrane interactions of IAPP17-29 peptide derivatives.
    Pappalardo G; Milardi D; Magrì A; Attanasio F; Impellizzeri G; La Rosa C; Grasso D; Rizzarelli E
    Chemistry; 2007; 13(36):10204-15. PubMed ID: 17902185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amyloidogenic propensities and conformational properties of ProIAPP and IAPP in the presence of lipid bilayer membranes.
    Jha S; Sellin D; Seidel R; Winter R
    J Mol Biol; 2009 Jun; 389(5):907-20. PubMed ID: 19427320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of IAPP fibrillation at anionic lipid membranes via IAPP-derived amyloid inhibitors and insulin.
    Sellin D; Yan LM; Kapurniotu A; Winter R
    Biophys Chem; 2010 Aug; 150(1-3):73-9. PubMed ID: 20153100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of the core structure of lysozyme amyloid fibrils by proteolysis.
    Frare E; Mossuto MF; Polverino de Laureto P; Dumoulin M; Dobson CM; Fontana A
    J Mol Biol; 2006 Aug; 361(3):551-61. PubMed ID: 16859705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Residual structure in islet amyloid polypeptide mediates its interactions with soluble insulin.
    Wei L; Jiang P; Yau YH; Summer H; Shochat SG; Mu Y; Pervushin K
    Biochemistry; 2009 Mar; 48(11):2368-76. PubMed ID: 19146426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing the structural properties of human and rat islet amyloid polypeptide by MD computer simulations.
    Andrews MN; Winter R
    Biophys Chem; 2011 Jun; 156(1):43-50. PubMed ID: 21266296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of His-18 in amyloid formation by human islet amyloid polypeptide.
    Abedini A; Raleigh DP
    Biochemistry; 2005 Dec; 44(49):16284-91. PubMed ID: 16331989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of protein sequence and amino acid composition in amyloid formation: scrambling and backward reading of IAPP amyloid fibrils.
    Sabaté R; Espargaró A; de Groot NS; Valle-Delgado JJ; Fernàndez-Busquets X; Ventura S
    J Mol Biol; 2010 Nov; 404(2):337-52. PubMed ID: 20887731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of highly compact type II diabetes related islet amyloid polypeptide intermediate species at physiological temperature revealed by diffusion NMR spectroscopy.
    Soong R; Brender JR; Macdonald PM; Ramamoorthy A
    J Am Chem Soc; 2009 May; 131(20):7079-85. PubMed ID: 19405534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative molecular dynamics study of human islet amyloid polypeptide (IAPP) and rat IAPP oligomers.
    Liang G; Zhao J; Yu X; Zheng J
    Biochemistry; 2013 Feb; 52(6):1089-100. PubMed ID: 23331123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure and thermodynamics of amylin dimer studied by Hamiltonian-temperature replica exchange molecular dynamics simulations.
    Laghaei R; Mousseau N; Wei G
    J Phys Chem B; 2011 Mar; 115(12):3146-54. PubMed ID: 21384830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.